Drug Shortage Report for ROBITUSSIN AC
Report ID | 96287 |
Drug Identification Number | 01934740 |
Brand name | ROBITUSSIN AC |
Common or Proper name | Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup |
Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CODEINE PHOSPHATE GUAIFENESIN PHENIRAMINE MALEATE |
Strength(s) | 10MG 100MG 7.5MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL |
Packaging size | 1 Litre |
ATC code | R05FA |
ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-09 |
Estimated end date | 2020-01-31 |
Actual end date | 2020-01-03 |
Shortage status | Resolved |
Updated date | 2020-11-12 |
Company comments | Manufacturing disruption has been rectified. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-11-12 | French | Compare |
v3 | 2020-11-12 | English | Compare |
v2 | 2019-10-11 | French | Compare |
v1 | 2019-10-11 | English | Compare |
Showing 1 to 4 of 4